The agency’s consolidation — intended to increase efficiency, according to Health and Human Services Secretary Robert F. Kennedy Jr. (pictured at left) — could acutely diminish research funding ...
Over the past several years, the health care and life sciences industry has faced persistent financial strain. Fragile supply chains, patent expirations, federal drug price negotiations, labor ...
Breaking news and analysis of biotech, life sciences and other emerging technologies and research impacting health and ...
I recently read an article about a father in the Midwest who faced a medical emergency one evening when his youngest child experienced severe stomach pain. With the nearest hospital hours away, he ...
Health Group today announced an eighth-year of record growth, driven by a broad slate of new client partnerships and ...
In today's digitally driven world, data has become the lifeblood of the healthcare and life sciences industry. From genomic sequencing data to real world patient records, data drives decision-making ...
HOBOKEN, N.J.--(BUSINESS WIRE)--Wiley (NYSE: WLY), one of the world’s largest publishers and a global leader in research and learning, today announced plans to further expand the prestigious Advanced ...
As we reach the halfway point of the decade, the rapid and continuing evolution of digital technologies puts us on the verge of fulfilling a long-promised transformation of the healthcare and life ...
What You Should Know At the Oracle Health and Life Sciences Summit, Oracle Health announced a major portfolio-wide expansion ...
The 137,000-sq-ft centre is Syneos Health's largest in Asia and third-largest globally, with an initial workforce of more than 700 professionals ...
In addition to the awards ceremony, an innovation summit was also organised with industry experts and government officials ...
Filament has shipped PEX010 to Bruyère Health Research Institute for its Phase 3 placebo-controlled trial, which follows a published Phase I/II study that found microdose psilocybin safe, feasible and ...